stockrow
Friday 6 November 2026
Export AMTX’s income statement to Excel — free account
Aemetis, Inc
AMTX Basic Materials Specialty Chemicals
Aemetis, Inc’s revenue for fiscal 2025 (year ended December 2025) was $197.6 million, down 26.2% from fiscal 2024.
- Revenue
- +48.9%
- EPS
- +118.9%
- Free cash flow
- +269.0%
- Total debt
- +12.6%
Quarter to September 2026, against a year earlier
1.62
0.11
−6.36%
Follow AMTX
Alert me
| Older periods | Dec '25 | Mar '26 | Jun '26 | Sep '26 From the 10-Q filed 5 Nov | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
0.00 | 0.00 | 0.00 | 0.00 |
P/S ratio |
0.42 | 1.02 | 0.53 | 0.52 | |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
P/Operating CF |
14.44 | (20.19) | (61.77) | 5.88 | |
P/B ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Sales |
2.13 | 2.69 | 2.19 | 2.01 | |
EV/EBITDA |
0.00 | 0.00 | 128.83 | 134.26 | |
EV/Operating CF |
129.18 | (75.69) | (133.48) | 32.75 | |
EV/FCF |
(18.54) | (14.78) | (12.21) | (13.69) | |
Quick Ratio |
0.03 | 0.03 | 0.04 | 0.01 | |
Current Ratio |
0.07 | 0.09 | 0.08 | 0.07 | |
Net Debt/EBITDA |
169.50 | (191.95) | 41.99 | 0.00 | |
Debt/Assets |
132.02% | 131.65% | 126.27% | 120.18% | |
Debt/Equity |
(1.12) | (1.11) | (1.13) | (1.19) | |
Asset Turnover |
0.76 | 0.82 | 0.83 | 0.90 | |
Operating CF/Net income |
(1.08) | 0.49 | 0.20 | 4.21 | |
Capex/Depreciation |
(3.70) | (1.45) | (2.94) | 0.00 | |
Interest Coverage |
(0.21) | (0.51) | 0.43 | 1.47 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
23.57% | 16.64% | 12.35% | 9.78% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
1.95% | 3.21% | 1.79% | 0.00% | |
Graham Net Nets |
(6.47) | (2.61) | (4.97) | (4.63) | |
Graham Number |
12.37 | 11.35 | 9.65 | 6.77 | |
Earnings Yield |
(95.68%) | (37.30%) | (55.49%) | (26.40%) | |
Free Cash Flow Yield |
(27.27%) | (17.92%) | (33.83%) | (28.35%) | |
Revenue per Share |
0.72 | 0.82 | 0.88 | 1.22 | |
Operating CF per Share |
0.10 | (0.16) | (0.03) | 0.30 | |
Capex per Share |
(0.28) | (0.10) | (0.12) | (0.28) | |
Free Cash Flow per Share |
(0.18) | (0.26) | (0.15) | 0.02 | |
Cash per Share |
0.08 | 0.07 | 0.01 | 0.05 | |
Shareholders Equity per Share |
(5.12) | (4.81) | (4.54) | (4.33) | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
(5.12) | (4.81) | (4.54) | (4.33) | |
Free Cash Flow |
(10.79) | (17.10) | (10.42) | 1.73 | |
Working Capital |
(344.39) | (361.56) | (382.03) | (410.70) | |
Capital Expenditures |
(16.56) | (6.55) | (8.53) | (20.22) | |
Net Current Asset Value |
(539.80) | (556.78) | (578.29) | (597.07) | |
EV/EBIT |
0.00 | 0.00 | 0.00 | 28.11 | |
Capex to Sales |
0.38 | 0.12 | 0.14 | 0.23 | |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 7.25 | |
| Other line items | |||||
Average Receivables |
10.03 | 3.81 | 8.59 | — | |
Average Payables |
28.28 | 27.92 | 26.59 | 33.26 | |
Average Inventory |
18.53 | 16.66 | 13.00 | 8.85 | |
Average Assets |
259.57 | 256.42 | 264.60 | 276.56 | |
Average Common Equity |
(285.38) | (300.92) | (305.68) | (309.53) |
Columns are period end dates · fundamentals updated 5 Nov 2026